CardioNet, Inc. (NASDAQ:BEAT) today announced that last week Highmark
Medicare Services posted a reimbursement rate for CPT code 93229, Mobile
Cardiovascular Telemetry Services, of $1,123.07 at: www.highmarkmedicareservices.com/partb/reimbursement/calc-2009.html.
Highmark Medicare Services had not posted a reimbursement rate for CPT
code 93229 since the CPT code was published by the AMA in October of
2008. The reimbursement of $1,123.07 reflects the same rate that the
Company announced in November 2008 on attaining the CPT code.
About CardioNet, Inc.
CardioNet, Inc. is the leading provider of ambulatory, continuous,
real-time outpatient management solutions for monitoring relevant and
timely clinical information regarding an individual's health.
CardioNet's initial efforts are focused on the diagnosis and monitoring
of cardiac arrhythmias, or heart rhythm disorders, with a solution that
it markets as Mobile Cardiac Outpatient Telemetry™ (MCOT™). More
information can be found at http://www.cardionet.com.
Forward Looking Statements
This press release includes certain forward-looking statements regarding
CardioNet, Inc. within the meaning of the “Safe Harbor” provisions of
the Private Securities Litigation Reform Act of 1995 regarding, among
other things, the reimbursement rates for CardioNet, Inc. products and
technology, which may change in the future, and the actions of Highmark
Medicare Services and the Centers for Medicare and Medicaid Services
(CMS), including actions related to reimbursement rates for CardioNet,
Inc. products and technology. These statements may be identified by
words such as “expect,” “anticipate,” “estimate,” “intend,” “plan,”
“believe,” and other words and terms of similar meaning. Such
forward-looking statements are based on current expectations and involve
inherent risks and uncertainties, including important factors that could
delay, divert, or change any of them, and could cause actual outcomes
and results to differ materially from current expectations. These
factors include, among other things, the ability of Highmark Medicare
Services and CMS to change reimbursement rates for CardioNet, Inc.
products and technology and the timing of any such change, changes in
governmental regulations and legislation, and other changes to
reimbursement levels for CardioNet’s products and technology. For
further details and a discussion of these and other risks and
uncertainties, please see CardioNet’s public filings with the Securities
and Exchange Commission, including CardioNet’s latest periodic report on
Form 10-K or 10-Q. CardioNet undertakes no obligation to publicly update
any forward-looking statement, whether as a result of new information,
future events, or otherwise.
CardioNet, Inc.
Marty Galvan
Investor Relations
800-908-7103
investorrelations@cardionet.com
